Open AccessEconomic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
Author(s) -
Soham Shukla,
Dhvani Shah,
Antonio Jiménez Martín,
Nancy Risebrough,
Robyn Kendall,
Claus Vogelmeier,
I. Boucot,
Lee Tombs,
Leif Bjermer,
Paul Jones,
Edward Kerwin,
Chris Compton,
François Maltais,
David A. Lipson,
Afisi S Ismaila
Publication year - 2021
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s331636
Subject(s) - medicine , salmeterol , discontinuation , copd , population , environmental health